Skip to main content

InvestorNewsBreaks – Applied DNA Sciences Inc. (NASDAQ: APDN) Has Closed Registered Direct Offering Resulting in $15M

Applied DNA Sciences (NASDAQ: APDN) (OTC: APPDW), a leader in polymerase chain reaction (“PCR”)-based DNA manufacturing, announced that it has officially closed the registered direct offering of 1,810,000 shares of common stock. The shares were sold at $8.30 per share, resulting in a total of $15 million for the company. APDN provides molecular technologies that enable supply chain security. The company also offers anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates. Sole placement agent for the offering was Roth Capital Partners.

To view the full press release, visit https://ibn.fm/REp08

About Applied DNA Sciences

Applied DNA is a provider of molecular technologies that enable supply chain security, anti-counterfeiting and anti-theft technology, product genotyping and pre-clinical nucleic acid-based therapeutic drug candidates. The company’s common stock is listed on NASDAQ under ticker symbol APDN (“APDN”), and its publicly traded warrants are listed on OTC under ticker symbol APPDW (“APPDW”). Applied DNA is a member of the Russell Microcap(R) Index. For more information about the company, please visit www.ADNAS.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.